国邦医药

- 605507

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017 
国邦医药(605507) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入441,814.72289,235.65133,870.30534,944.79405,347.68
营业收入441,814.72289,235.65133,870.30534,944.79405,347.68
二、营业总成本372,461.55239,720.64110,009.72465,482.08347,855.36
营业成本326,200.88212,311.5497,146.08409,711.88305,417.07
营业税金及附加3,209.331,937.39697.513,619.292,311.79
销售费用5,046.723,224.531,722.747,419.795,385.13
管理费用22,809.2915,061.037,574.6230,308.2922,954.99
财务费用-833.41-2,109.86-896.69-4,628.23-4,489.73
研发费用16,028.759,296.003,765.4619,051.0716,276.11
资产减值损失----------
公允价值变动收益1,013.82581.16-38.031,034.22--
投资收益1,145.161,028.01726.901,322.11467.14
其中:对联营企业和合营企业的投资收益-130.22-45.33-69.536.05-153.07
汇兑收益----------
三、营业利润67,394.7747,245.9323,610.5470,226.3556,397.58
加:营业外收入343.60260.4448.21331.51211.71
减:营业外支出1,275.121,097.45256.39793.00654.23
其中:非流动资产处置损失----------
四、利润总额66,463.2446,408.9123,402.3569,764.8655,955.06
减:所得税费用8,599.425,972.023,544.488,766.997,189.48
五、净利润57,863.8240,436.9019,857.8760,997.8748,765.57
归属于母公司所有者的净利润57,888.4940,459.7919,873.1161,246.4148,907.33
少数股东损益-24.67-22.89-15.24-248.55-141.75
六、每股收益
基本每股收益(元/股)1.04000.73000.36001.10000.8800
稀释每股收益(元/股)1.04000.73000.36001.10000.8800
七、其他综合收益----------
八、综合收益总额57,863.8240,436.9019,857.8760,997.8748,765.57
归属于母公司所有者的综合收益总额57,888.4940,459.7919,873.1161,246.4148,907.33
归属于少数股东的综合收益总额-24.67-22.89-15.24-248.55-141.75
下载全部历史数据到excel中 返回页顶